Mlp Saglik Hizmetleri As Class B · BIST:MPARK

Mlp Saglik Hizmetleri As Class B — MLP Care — 9M 2022 Earnings Presentation

25 slides from Mlp Saglik Hizmetleri As Class B's earnings presentation, Nov 8, 2022

1. Slide 1: MLPCARE 9M 2022 Presentation

   MLPCARE 9M 2022 PRESENTATION N o v e m b e r 8 th, 2 0 2 2

2. Slide 2: Forward Looking Statements

   Forward Looking Statements This presentation may contain certain forward-looking statements concerning MLP Care’s future performance and should be considered as good faith estimates made by the Company. These forward-looking statements reflect management expectations and are based upon currently ava

3. Slide 3: Muharrem Usta, Chairman & CEO

   MUHARREM USTA CHAIRMAN & CEO

4. Slide 4: At a Glance: MLP Care Q3 2022 Financial Highlights

   At a Glance: MLP Care Q3 2022 Financial Highlights  Revenue growth exceeding inflation Revenue EBITDA  EBITDA improved mainly due to TL 2,476 m TL 590 m  strong operational performance 65% Growth 48% Growth  effective cost saving measures 9M 2022: 9M 2022: 71% Growth 64% Growth  Reduced leverag

5. Slide 5: Top-up Insurance Users Reached 3.1 m

   # of People Top-up Insurance Users Reached 3.1 m # of People with Insurance in Turkey (in thousand) 2,602 3,084 5,686 2,453 2,192 4,645 Growth (9M 2022 – 9M 2021) 6.1% 40.7% 22.4% PMI Top-up PMI+Top-up # of People with Top-up Insurance in Turkey (in thousand) 9.2022; 3,084 9.2021; 2,192 Average LTM

6. Slide 6: FMT Revenue Triples in TL Terms

   FMT Revenue Triples in TL Terms Medical Tourism Revenue (USD m) TOP 10 FMT Revenue % by Department in 9M 2022 35.0% 77 13% 11% 11% 57 8% 13.6% 5% 5% 3% 3% 3% 3% Gynecology and Hematology Urology Brain and Neuro General Surgery Cardiology Radiation Oncology Orthopedics Medical Oncology Pediatric Hema

7. Slide 7: Liv Hospital Brand Expands in Baku

   Liv Hospital Brand Expands in Baku Map of Azerbaijan Liv Bona Dea Hospital Location: Baku / Azerbaijan Opening Date: July 2022 Key Statistics  37.5k sqm  156 Bed Capacity  28 Intensive Care Unit  12 Operating Rooms 7

8. Slide 8: Our Sustainability Strategy

   Our Sustainability Strategy 8

9. Slide 9: Our Sustainability Targets

   Our Sustainability Targets 9

10. Slide 10: Slide 10

11. Slide 11: Revenue Grows Above Inflation

    Revenue Grows Above Inflation Revenue (TLm) 6,893 89.9% 70.6% 93.4% 4,040 65.3% 2,476 1,498 Q3 2021 Q3 2022 9M 2021 9M 2022 Denotes growth of Revenue vs. the same period of the last year 11 Denotes growth of Revenue vs. the same period of the last year excluding Sentez

12. Slide 12: All Payer Types Continue to Grow

    All Payer Types Continue to Grow 9M 2022 75%  Revenue from SSI was up by 12% in Q3 2022 3% 27% (SSI Insurance allows for a wide addressable market, 165% which is c.98% of the total population) 19% 18%  Self pay was up by 60% in Q3 2022  Revenue from PMI, Top-up & Contracted Institutions was up by

13. Slide 13: All Revenue Segments Continue to Grow

    All Revenue Segments Continue to Grow Domestic Patient Medical Tourism Ancillary Business Revenue Revenue 57.9% 164.6% 75.2% 5,461 138.2% 214 56.5% 1,217 (7.1%) 1,929 493 54 Q3 2022 9M 2022 Q3 2022 9M 2022 Q3 2022 9M 2022 Domestic Revenue q-o-q Growth Accelerated Growth of Foreign Increase in Manage

14. Slide 14: Continued Improvement in Average Prices

    Continued Improvement in Average Prices Outpatient Revenues (TLm) Inpatient Revenues (TLm) 67.1% 51.5% 59.8% 23.4% 7.3% 28.1% 476 851 104 572 2,380 3,081 1,424 2,033 9M 2021 Volume & Mix Price 9M 2022 9M 2021 Volume & Mix Price 9M 2022 Average Revenue Per Visit (ARPV) Average Revenue Per Protocol (A

15. Slide 15: EBITDA Is Up By 64%

    EBITDA Is Up By 64% EBITDA (TLm)1 74.8% 1,629 63.9% 66.4% 994 48.1% 590 398 Q3 2021 Q3 2022 9M 2021 9M 2022 1 EBITDA and EBITDA margin calculated by deducting general administrative expenses from gross profit and adding depreciation and amortization expenses Denotes growth of EBITDA vs. the same per

16. Slide 16: Prudent Cost Management

    Prudent Cost Management Cost of Service and G&A Expenses as a % of Revenues Cost Saving Measures enables us to reach the favourable EBITDA Margin EBITDA Margin 24.6% 23.6%  Material costs as a % of revenue decreased in 9M 2022 due to the lagging effect of increased costs on the back 0.9% 1.1% of ef

17. Slide 17: Bottom Line Improves on The Back of Strong Operations

    Bottom Line Improves on The Back of Strong Operations Net Profit (TLm) Net Profit (TLm) Allocated to Equity Holders of the Parent 517.8% 529.4% 401.4% 1,079 1,039 5,042.4% 1,062.7% 2,510.0% 475 462 215 41 18 18 165 Q3 2021 Q3 2022 9M 2021 9M 2022 Q3 2021 Q3 2022 9M 2021 9M 2022 Denotes growth of Net

18. Slide 18: Leverage Ratios Continue to Decline

    Leverage Ratios Continue to Decline 2,500 4.0 Net Debt (TLm) 3.5 2,000 2,116 2,069 3.0 1,500 1,521 2.5 1,452 2.2x Reduction 345mTL 2.0 1,000 1,176 1.5x 1.5 500 Reduction 579mTL 597 1.0 0.7x - 0.5 2020 2021 9M 2022 Net Debt (exc. IFRS 16) Net Debt (inc. IFRS 16) Net Debt/EBITDA FX risk of balance sh

19. Slide 19: Strong Cash Generation

    Strong Cash Generation Maintenance Capex (TLm) Total Capex (TLm) OCF/ EBITDA FCF/ EBITDA 83.3% 57.7% 3.6% 55.2% 6.7% 26.6% 2.6% 574 246 6.1% 828 900 463 434 104 245 9M 2021 9M 2022 9M 2021 9M 2022 9M 2021 9M 2022 9M 2021 9M 2022 % of Revenue % of Revenue % of EBITDA % of EBITDA 19

20. Slide 20: Q&A

    Q&A

21. Slide 21: Closing Remarks

    Closing Remarks MUHARREM USTA CHAIRMAN & CEO

22. Slide 22: Thank You!

    Thank You! MLP Care Investor Relations Deniz Can Yücel +90 212 227 5555 (Ext: 1148) deniz.yucel@mlpcare.com http://investor.mlpcare.com/en/

23. Slide 23: Historical Balance Sheet

    Historical Balance Sheet Unaudited Unaudited Audited TLm September 30, 2022 September 30, 2021 December 31, 2021 Cash and cash equivalents 994 676 680 Financial investments 214 - - Trade receivables 1,303 1,359 1,318 Inventory 539 122 285 Short term other assets 661 537 458 Current assets 3,711 2,69

24. Slide 24: Historical P&L Statements

    Historical P&L Statements Unaudited Unaudited Unaudited Unaudited Change (%) Change (%) TLm 9M 2022 9M 2021 Q3 2022 Q3 2021 Revenues 6,893 4,040 70.6% 2,476 1,498 65.3% Cost of service (-) (4,938) (2,969) 66.3% (1,749) (1,062) 64.7% Gross profit 1,954 1,071 82.5% 726 435 66.9% General administration

25. Slide 25: EBITDA Reconciliation

    EBITDA Reconciliation TLm 9M 2022 9M 2021 Q3 2022 Q3 2021 Revenue 6,893 4,040 2,476 1,498 Cost of service 4,938 2,969 1,749 1,062 Gross profit 1,954 1,071 726 435 General administrative expenses (-) (642) (314) (243) (121) Depreciation and amortization expenses (Cost of service) 294 222 98 78 Deprec

MLP Care — 9M 2022 Earnings Presentation on 6ix